A detailed history of Versant Capital Management, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Versant Capital Management, Inc holds 996 shares of NVO stock, worth $84,689. This represents 0.02% of its overall portfolio holdings.

Number of Shares
996
Holding current value
$84,689
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$85.0 - $120.04 $84,660 - $119,559
996 New
996 $85,000
Q3 2023

Oct 11, 2023

BUY
$90.94 - $199.54 $5,274 - $11,573
58 Added 100.0%
116 $10,000
Q1 2023

Apr 10, 2023

BUY
$132.34 - $159.14 $7,675 - $9,230
58 New
58 $9,000
Q1 2018

Apr 19, 2018

SELL
$48.49 - $58.14 $9,698 - $11,628
-200 Closed
0 $0
Q4 2017

Apr 19, 2018

BUY
$47.53 - $53.73 $9,506 - $10,746
200
200 $10,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.